Back to News
Market Impact: 0.2
Corcym Announces First-In-Human Implant of Memo 4D Curve™, Expanding Its Memo Mitral Repair Platform
Source: Business Wire
Healthcare & BiotechProduct LaunchesTechnology & Innovation
Corcym announced the first-in-human use of its Memo 4D Curve open-configuration annuloplasty ring for mitral valve repair. The milestone validates initial clinical deployment of the new cardiac-surgery device, though no patient outcomes, revenue impact, or commercialization timeline were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly positive
Sentiment Score
0.55
More News
- Wall Street’s Nasdaq hits all-time high as AI frenzy gathers pace
- Data-Center Bet Makes ESDS One of India’s Best New Listings
- Asia stocks ride tech wave higher, oil stays subdued
- Trump Says US Team Met With Iranians at UNGA
- U.S. regulators rush to write crypto rulebook after Clarity Act stalls in Senate
- Meta is breaking out after introducing Muse AI agent. Where the stock is going, according to the charts
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AllMind Discusses Ontario's AI Economy with Minister Stephen Crawford and Supply Ontario CEO James Wallace
- AI Research Tools for SEDAR+, UK and ASX Filings